Engelsen
Kristian Engelsen, Peoria, IL US
Patent application number | Description | Published |
---|---|---|
20140174060 | System and Method for Accommodating Aftertreatment Bricks - One or more aftertreatment bricks are axially inserted through an opening in the first end of a tubular sleeve of an aftertreatment system. The aftertreatment brick includes a substrate matrix and a mantle disposed around the substrate matrix. The mantle further includes a lip arranged to extend through the opening of the sleeve. One or more channel pockets are secured proximate to the opening of the sleeve and oriented radially outward with respect to the sleeve axis. To retain the aftertreatment brick in the sleeve, a clamping assembly is used that includes a hook, a fastener, and a capture nut. The capture nut is installed and accommodated in the channel pockets. The hook engages the protruding lip of the aftertreatment brick and the fastener secures the hook to the capture nut received in the channel pocket. | 06-26-2014 |
Kristian N. Engelsen, South Bend, IN US
Patent application number | Description | Published |
---|---|---|
20140044612 | After-Treatment System - An after-treatment system includes a Selective Catalytic Reduction (SCR) catalyst or a similar aftertreatment unit or brick that may be inserted into the opened end of a sleeve. The aftertreatment brick includes a substrate matrix with catalytic material that extends between a first face and a second face. A mantle is disposed around the substrate matrix and extends between a first rim proximate the first face and a second rim proximate the second face. The mantel may include a overhang extension that extends the first rim of the mantle beyond the first face of the substrate matrix. To enable retrieval of the SCR catalyst from the sleeve, a retrieval feature is disposed on a readily accessible, inner surface of the overhang extension. | 02-13-2014 |
20140283528 | Aftertreatment Module and Method of Assembly - To assemble an aftertreatment module for use in the treatment of exhaust gasses and the like, an aftertreatment brick is inserted into a sleeve opening in a sleeve and advanced toward an opposite end of the sleeve. To retain the aftertreatment brick in the sleeve, the end of the sleeve can include a stop flange and the aftertreatment brick can include a mantle flange. The stop flange and the mantle flange can abut against each other to prevent further movement of the aftertreatment brick through the sleeve. To seal against exhaust gasses leaking though the module, a gasket can be disposed between the stop flange and the mantle flange. Exterior ribs disposed around the aftertreatment brick can assist concentric alignment between the flanges and gasket. | 09-25-2014 |
Kristian N. Engelsen, Peoria, IL US
Patent application number | Description | Published |
---|---|---|
20130145820 | SENSOR MOUNTING ARRANGEMENT - An arrangement for mounting at least one electrical component to a portion of an aftertreatment module, the arrangement including; at least one standoff member coupled between the electrical component and the portion of the aftertreatment module, and an enclosure substantially surrounding at least three sides of the electrical component. | 06-13-2013 |
Merete Moeller Engelsen, Frederiksberg DK
Patent application number | Description | Published |
---|---|---|
20120288585 | Methods of Producing GH8 Xylanase Variants - The present invention relates to isolated polypeptides having xylanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides. | 11-15-2012 |
20130273198 | Preparation of Baked Product From Dough - The present invention relates to a method for producing a baked product comprising preparing a dough comprising at least whole meal flour, a GH61 polypeptide, and a cellulase, and baking the dough to form the baked product. The present invention relates also to a baking composition comprising a GH61 polypeptide, a cellulase, and optionally flour. The present invention relates also to the use of a GH61 polypeptide and a cellulase for producing a baked product, e.g. a baked product, prepared from whole meal flour. | 10-17-2013 |
Søren Balling Engelsen, Frederiksberg DK
Patent application number | Description | Published |
---|---|---|
20110004453 | METHOD FOR PREDICTION OF LIPOPROTEIN CONTENT FROM NMR DATA - The invention concerns a method of preparing regression coefficients in a multivariate analysis for predicting the quantity of a component of a lipoprotein entity in a biological sample from NMR spectral data and a method of predicting the quantity of a component of a lipoprotein entity in a biological sample from NMR spectral data, which is based on the regression coefficients. The invention is especially useful for predicting the triacylglycerol level in chylomicrons of a patient. | 01-06-2011 |
Steinar Johan Engelsen, Tromso NO
Patent application number | Description | Published |
---|---|---|
20130273025 | ORAL VETERINARY PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS - This invention provides an oral veterinary pharmaceutical or nutraceutical composition comprising a physiologically tolerable gelled oil-in-water emulsion further comprising at least one component selected from taste enhancers, odour enhancers, digestive enzymes and veterinary drugs. | 10-17-2013 |
Steinar Johan Engelsen, Stabekk NO
Patent application number | Description | Published |
---|---|---|
20140005179 | ORAL PHARMACEUTICAL DISPERSION COMPOSITIONS | 01-02-2014 |
20140163108 | ORAL PHARMACEUTICAL DISPERSION COMPOSITIONS - The invention provides an oral pharmaceutical composition, optionally in dose unit form, comprising a lipophilic drug substance in dispersion in a physiologically tolerable aqueous carrier, preferably an aqueous gel, wherein said drug substance contains a functional electrostatic group having a pKa value of from 2 to 10, characterised in that said aqueous carrier has a pH at least 0.3 below or above said pKa value, said pH being below said pKa where said group is acidic and above said pKa where said group is basic. | 06-12-2014 |